Boulder Peptide Symposium 2024

Peptide Showcase: Menten AI, Inc.

Menten AI's CEO, Dr. Hans Melo, will be sharing the latest developments at Menten AI in Boulder on adding drug-like properties including plasma stability and membrane-permeability.